A leading company in promoting clinical transformation of biotherapeutic technologies

Unremitting efforts to improve human health

About Beike Biotechnology

Shenzhen Beike Biotechnology Co., Ltd. (hereinafter referred to as “Beike Bio”) was founded in July 2005. The company’s headquarters is located on the shore of the beautiful Shenzhen Bay and Houhai. The company currently has more than 740 employees, of which more than 40% are technical R&D personnel. Beike Bio is a national high-tech enterprise specializing in the clinical transformation and technical services of strategic emerging industry biotherapy technology. It has a professional technical R&D team led by many experts and domestic and foreign scholars with outstanding achievements in the field of cells.

Independent R&D platform
7 item
Ongoing research projects
7 item
Patent application
207 item
Published in authoritative magazine
100 +Articles
Staff
740 +
National Projects
7 item

Comprehensive Cell Bank and Regional Cell Preparation Center Network

“Laying” a “cell highway network” that can meet the timeliness of clinical needs while taking into account production scale, connecting clinical demanders and advanced technology suppliers.

At present, the construction of infrastructure for the cell therapy industry covering South China, East China, Central China, North China, Southwest China, and Northwest China has been realized.

Build a standardized cell storage and preparation model that meets international standards and development trends, and provide an innovative public technology platform and infrastructure for the clinical transformation of cell therapy technology

Service Areas

News Center

A Tale of Two Spinal Cord Injury Patients

learn more

Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease...

Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co., Biomaster Inc....

Stem Cell Leader Beike Biotech and China’s Tsinghua University Receive USD $4 Million for Stem Cell...